Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Jul
26
2018
 The Parade of Horribles Fallacy: § 285 Attorneys’ Fees Implicit Notice Requirement McDermott Will & Emery
Jul
25
2018
 Getting The Last Word: Requesting a Patent Owner Sur-Reply in AIA-PTAB Proceedings Foley & Lardner LLP
Jul
24
2018
 How You Can Utilize the USPTO’s Berkheimer Memorandum During Application Drafting, Prosecution and Appeal Covington & Burling LLP
Jul
24
2018
 Federal Circuit Rejects Tribal Sovereign Immunity Defense in IPR Proceedings Brinks Gilson & Lione
Jul
24
2018
 When Public Use Qualifies for the Experimental Use Exception to 35 U.S.C. § 102(b) Mintz
Jul
24
2018
 CAFC Finds Publication Did Not Inherently Disclose Aveed Composition Foley & Lardner LLP
Jul
24
2018
 The Federal Circuit Shuts the Door on Use of Tribal Immunity in IPRs Squire Patton Boggs (US) LLP
Jul
21
2018
 Federal Circuit Affirms PTAB Ruling That Tribal Immunity Does Not Apply To IPRs Foley & Lardner LLP
Jul
17
2018
 Ranging Beyond The Written Description Requirement Foley & Lardner LLP
Jul
10
2018
 Federal Circuit Upholds Zomig Patents Finding Intranasal Delivery Not Obviousness Foley & Lardner LLP
Jul
9
2018
 Federal Circuit Decision in Medical Device Case Sheds Light on “Exceptionality” Analysis for Attorney Fees Covington & Burling LLP
Jul
3
2018
 USITC Issues Important Opinion Concerning Section 337’s Domestic Industry Requirement Squire Patton Boggs (US) LLP
Jun
28
2018
 Finjan, Inc. v ESET, LLC: Can Billing Records Evidence Intent Element of Inequitable Conduct? Schwegman, Lundberg & Woessner, P.A.
Jun
28
2018
 A Forum Selection Clause Provides No Basis For Terminating A Section 337 Investigation Squire Patton Boggs (US) LLP
Jun
27
2018
 Breaking News! Supreme Court Gives Patent Owners Big Win Dickinson Wright PLLC
Jun
26
2018
 Federal Circuit, USPTO Clarify Subject Matter Eligibility for Methods of Treatment Foley & Lardner LLP
Jun
26
2018
 Federal Circuit Chastises PTAB Over Moving Target On Ex Parte Appeal Foley & Lardner LLP
Jun
23
2018
 Seeking Attorneys’ Fees Under the Patent Act? Early and Clear Notice of an Opposing Party’s Deficient Litigation Conduct Is a Prerequisite for a Successful Motion Squire Patton Boggs (US) LLP
Jun
22
2018
 With its Vanda Pharma and Berkheimer memos, USPTO provides increased clarity around personalized medicine patent eligibility Mintz
Jun
20
2018
 Recent Developments at the USPTO Covington & Burling LLP
Jun
19
2018
 The Hobson's Choice Of The Hatch-Waxman Integrity Act Foley & Lardner LLP
Jun
15
2018
 SAS "Ground" Rules Foley & Lardner LLP
Jun
14
2018
 Appeals Court Rejects Insurers Risk Corridors Claims Mintz
Jun
11
2018
 USPTO Vanda Memo Emphasizes Patent Eligibility Of Method Of Treatment Claims Foley & Lardner LLP
Jun
11
2018
 Patent Venue Mandamus Has Its Limits Squire Patton Boggs (US) LLP
Jun
5
2018
 PTAB Releases Frequently Asked Questions About The Implications Of SAS on AIA Trial Proceedings Foley & Lardner LLP
Jun
5
2018
 Federal Circuit Finds Incorporation By Reference Inadequate For Priority Claim Foley & Lardner LLP
Jun
4
2018
 Ex Parte Galloway – Berkheimer Meet s. 103 Schwegman, Lundberg & Woessner, P.A.
Jun
1
2018
 SAS Institute: One Month In Foley & Lardner LLP
May
30
2018
 The Expanded Scope of the Printed Matter Doctrine and Effect on “Mental Steps” Brinks Gilson & Lione
May
29
2018
 Federal Circuit Holds Federal Circuit Law Applies to Patent Venue Challenges and Places Burden on Plaintiffs to Establish Venue Mintz
May
29
2018
 Ex Parte Smith: What We’ve Got Here Is A Failure To Communicate! Schwegman, Lundberg & Woessner, P.A.
May
29
2018
 Federal Circuit Finds INOMax Mental Steps Obvious As Ineligible Printed Matter Foley & Lardner LLP
May
28
2018
 Medical Treatment Patent Claims Held Patentable Subject Matter Under the Alice/Mayo Section 101 Test Foley & Lardner LLP
May
25
2018
 Ex parte Galloway – Two Correlations are Better than One Schwegman, Lundberg & Woessner, P.A.
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters